Biggest News Aggregation in the World
📰 Action Hepatitis News

Action Hepatitis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Action Hepatitis. Real-time updates on events, politics, business and more.

MAVIRET® (glecaprevir/pibrentasvir) Approved by Health Canada for Paediatric Patients with Chronic Hepatitis C

MAVIRET can now be used as an 8-week, once-daily paediatric granule formulation option in treatment-naïve, without cirrhosis or with compensated cirrhosis, chronic Hepatitis C paediatric... | June 22, 2022
Glecaprevir Pibrentasvir Jennifer Van Gennip Tracey Ramsay Division Of Gastroenterology Canadian Network On Hepatitisc Canhep World Health Organization

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science